eternumviti
Insufficient privileges to reply.
In my own words (and based on nothing more than reading the press), the UK cut a few corners in its normal approval process to save a few weeks, as the situation was dire and BoJo was so very desperate to prove the UK is "world beating" once liberated from the shackles of EU bureaucrats. He was perhaps disappointed to have to use a German/US vaccine rather than a pukka world-beating Oxford vaccine, but nothing's perfect. As a result, some OAPs were vaccinated a few weeks earlier, undoubtedly a good thing as the UK is also world-leading when it comes to COVID infections and deaths. As a minor fringe benefit, people like you luuurved it. "So much longer" is Brexiter hyperbole. We're talking weeks, these things normally take years. By the time the UK and other large countries are done vaccinating their people, a few weeks will probably appear to be a small variation. By Jan 6, the UK had administered Jab1 to 1.3% of its population. The UK has also chosen to take qualified risks by spacing out the first and the second jab up to 12 weeks, maybe a sensible thing to do in the circumstances but not tested or backed by any data.
The EC decided early on to spread its advance purchases among 6 manufacturers, back when it was not so clear which technology would come up with a viable vaccine in time. Some pharma companies were very successful (BioNTech, Moderna), others are months or even years late. With the benefit of hindsight, the EC would have bought more from BioNTech, but back then it was probably a reasonable strategy. BioNTech has predictably blamed the EU for not ordering enough of their vaccine (frittering away money on competitors' vaccines, tsss, how could they). Additionally, BioNTech is having trouble ramping up production. I won't blame them or anyone else, the manufacturing and logistical challenges must be horrendous.
Germany's acquisition of extra doses in September was followed by the EU ordering an extra 100 million doses, and they are negotiating for more again. These total numbers don't mean as much as who gets what this week, next week etc, and the capability to administer the jabs in time (all down to each country: France got 500K doses in Dec and should get 2M in January, but the actual vaccinations have barely started). Germany has had trouble getting enough doses of the vaccine it developed into people, whether due to shortage of vaccines or lack of facilities to administer the jabs I don't know, and many people in Germany felt they should have had first dibs. The fact that the German government has resisted this sort of rhetoric and stuck to the pooling approach is to its credit.
All just so in a soft, fluffy, creamed potatoey kind of way, until your last sentence, a statement that is entirely contrary to the facts. Germany didn't stick to the pooling approach, because it went back and nabbed another 30 million doses in direct contravention of the pooling approach that it had both sponsored and signed up to. Sure, the EU went back too, afterwards, but then of course it had a right to under those same pooling rules.